IPHA
Innate Pharma
IPHA
IPHA
4 hedge funds and large institutions have $5.71M invested in Innate Pharma in 2020 Q4 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
-2
Holders Change %
-33.33%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$14.6K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Wellington Management Group
Boston,
Massachusetts
| $5.46M | -$89.7K | -21,945 | -2% |
|
2
Millennium Management
New York
| $224K | -$73.6K | -17,960 | -25% |
|
|
3
Morgan Stanley
New York
| $21K | +$14.6K | +3,559 | +227% |
|
|
SPIA
4
Steward Partners Investment Advisory
New York
| $4K | – | – | – |
|
|
RCMNY
5
Rubric Capital Management (New York)
New York
| – | -$960K | -250,000 | Closed |
|
6
Osaic Holdings
Scottsdale,
Arizona
| – | -$8K | -2,000 | Closed |
|